Your browser doesn't support javascript.
loading
Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning.
Mueller, Yvonne M; Schrama, Thijs J; Ruijten, Rik; Schreurs, Marco W J; Grashof, Dwin G B; van de Werken, Harmen J G; Lasinio, Giovanna Jona; Álvarez-Sierra, Daniel; Kiernan, Caoimhe H; Castro Eiro, Melisa D; van Meurs, Marjan; Brouwers-Haspels, Inge; Zhao, Manzhi; Li, Ling; de Wit, Harm; Ouzounis, Christos A; Wilmsen, Merel E P; Alofs, Tessa M; Laport, Danique A; van Wees, Tamara; Kraker, Geoffrey; Jaimes, Maria C; Van Bockstael, Sebastiaan; Hernández-González, Manuel; Rokx, Casper; Rijnders, Bart J A; Pujol-Borrell, Ricardo; Katsikis, Peter D.
Afiliação
  • Mueller YM; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Schrama TJ; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Ruijten R; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Schreurs MWJ; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Grashof DGB; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van de Werken HJG; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Lasinio GJ; Cancer Computational Biology Center, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Álvarez-Sierra D; Department of Statistical Sciences, University of Rome "La Sapienza", Roma, Italy.
  • Kiernan CH; Immunology Division, Hospital Universitari Vall d'Hebron, Campus Vall d'Hebron, Barcelona, Spain.
  • Castro Eiro MD; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Meurs M; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Brouwers-Haspels I; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Zhao M; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Li L; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Wit H; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Ouzounis CA; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Wilmsen MEP; School of Informatics, Faculty of Sciences, Aristotle University of Thessaloniki, Thessalonica, Greece.
  • Alofs TM; Chemical Process & Energy Resources Institute, Centre for Research & Technology Hellas, Thermi, Thessalonica, Greece.
  • Laport DA; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Wees T; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Kraker G; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Jaimes MC; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Van Bockstael S; Cytek Biosciences, Fremont, CA, USA.
  • Hernández-González M; Cytek Biosciences, Fremont, CA, USA.
  • Rokx C; Cytek Biosciences, Fremont, CA, USA.
  • Rijnders BJA; Immunology Division, Hospital Universitari Vall d'Hebron, Campus Vall d'Hebron, Barcelona, Spain.
  • Pujol-Borrell R; Cell Biology, Physiology and Immunology Department, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Katsikis PD; Translational Immunology Research Group, Vall d'Hebron Institut de Recerca (VHIR), Campus Vall d'Hebron, Barcelona, Spain.
Nat Commun ; 13(1): 915, 2022 02 17.
Article em En | MEDLINE | ID: mdl-35177626

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Citocinas / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Citocinas / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda